Vaccine Injury Compensation: How the VICP Works and What It Covers

How the National Vaccine Injury Compensation Program works, which injuries qualify, how much it pays, and what happens when claims are denied.

The InfoNexus Editorial TeamMay 23, 20269 min read

$5.7 Billion Paid Out: The Quiet Federal System Behind Vaccine Injury Claims

Since 1988, the National Vaccine Injury Compensation Program (VICP) has paid out more than $5.7 billion in compensation to individuals and families who suffered serious adverse events following vaccination. Most Americans have never heard of it. Created by the National Childhood Vaccine Injury Act of 1986, the VICP was designed to ensure a stable vaccine supply by shielding manufacturers from direct litigation while still providing a no-fault compensation path for injured individuals. Understanding how it works is essential for anyone who believes they or a family member suffered a serious vaccine-related injury.

The VICP is not a perfect system, and critics on both sides debate its adequacy. What is clear is that it resolves the vast majority of vaccine injury claims faster and with lower legal costs than traditional civil litigation.

How the VICP Was Created

In the early 1980s, a wave of lawsuits against vaccine manufacturers — driven largely by DTP vaccine concerns — threatened to make manufacturers exit the market. Congress responded by creating a no-fault alternative dispute resolution system funded by an excise tax of $0.75 per antigen in covered vaccines. The program is administered by the Health Resources and Services Administration (HRSA), and cases are adjudicated in the U.S. Court of Federal Claims, informally called the "Vaccine Court."

Before suing a vaccine manufacturer in civil court, petitioners must first exhaust their claims in the VICP — a requirement known as the prior exhaustion rule. Only if the claim is denied or compensation is rejected can a petitioner pursue a traditional lawsuit.

Which Vaccines Are Covered

Vaccine CategoryExamplesCoverage Requirement
Childhood vaccines recommended by CDCDTaP, MMR, IPV, Hib, Hepatitis B, Varicella, PCVCovered; excise tax paid at purchase
Adult vaccines recommended by CDCInfluenza, Td/Tdap, Pneumococcal, Hepatitis ACovered since 1997 expansion
COVID-19 vaccines (mRNA and others)Pfizer-BioNTech, Moderna, J&JHandled separately under CICP (not VICP)
Experimental or emergency-use vaccinesVaries by authorization statusTypically CICP, not VICP

COVID-19 vaccines fall under the Countermeasures Injury Compensation Program (CICP), a separate and more restrictive system with lower compensation limits and no attorney fee reimbursement.

The Vaccine Injury Table

The centerpiece of the VICP is the Vaccine Injury Table — a federally maintained list that links specific vaccines to specific adverse events and time windows. If a petitioner's injury matches a table entry, causation is presumed and compensation is awarded without requiring proof that the vaccine caused the injury. This "table injury" shortcut dramatically speeds resolution.

  • MMR vaccine → Encephalopathy: Onset within 5–15 days of vaccination is a table injury.
  • Any vaccine → Anaphylaxis: Onset within 4 hours is a table injury.
  • Influenza vaccine → Guillain-Barré Syndrome: Onset 3–42 days post-vaccination is a table injury.
  • DTaP → Shoulder Injury Related to Vaccine Administration (SIRVA): Onset within 48 hours is a table injury.

SIRVA — shoulder pain and limited range of motion from an improperly administered injection — has become the most common compensated injury in recent years, accounting for roughly 60% of VICP settlements. It is not caused by the vaccine itself but by improper injection technique.

Off-Table Claims: The Harder Path

Most petitioners do not have a table injury and must prove causation directly — a more difficult and time-consuming process. The legal standard, established in Althen v. Secretary of HHS, requires petitioners to show: (1) a medical theory causally connecting the vaccine and injury, (2) a logical sequence of cause and effect, and (3) a proximate temporal relationship between vaccination and the onset of symptoms. Expert testimony is central to off-table claims, and many are contested vigorously by the government.

Compensation Available

Damage CategoryMaximum / Structure
Unreimbursed medical expenses (past)Actual costs, no cap
Future medical expensesActual projected costs, no cap
Lost earnings (past and future)Actual loss, no cap
Pain and suffering (non-economic)$250,000 lifetime cap
Death benefit$250,000 to the estate
Attorney fees and costsPaid regardless of outcome for reasonable claims

The $250,000 pain and suffering cap has not been adjusted for inflation since 1989 — a persistent criticism of the program. In cases with catastrophic lifetime injuries, the non-economic cap is often inadequate, but lifetime medical costs are uncapped and can reach into the millions.

Timeline and Process

Petitioners have three years from the first symptom of a vaccine injury to file a VICP claim (or two years from death, with six years from vaccination). A Special Master — a judicial officer in the Court of Federal Claims — presides over the case. The government's Department of Health and Human Services investigates and responds. Roughly two-thirds of adjudicated VICP claims result in compensation, though the overall resolution rate including dismissed cases is lower. Average resolution time for compensated claims is approximately 2.5 years; contested off-table cases can take 5–7 years.

This article is for informational purposes only and does not constitute legal advice.

vaccine injuryconsumer lawcompensation programs

Related Articles